OVERVIEW

Inherited Gastrointestinal Cancers and Genetic Testing is organized by Columbia University Vagelos College of Physicians and Surgeons (VP&S). This Online CME Course will be held on Oct 05, 2020, as a virtual event.

How many CME credits can be earned by attending the Inherited Gastrointestinal Cancers and Genetic Testing CME Course?

Accreditation:
The Columbia University Vagelos College of Physicians and Surgeons is authorized by the Accreditation Council for Continuing Medical Education to present continuing medical education for physicians.

AMA Credit Designation Statement:
The Columbia University Vagelos College of Physicians and Surgeons assigns this online activity for a maximum of 6.25 AMA PRA Category 1 Credits™. Physicians will be able to claim only the credit commensurate with the extent of their participation in the activity.

The National Society of Genetic Counselors (NSGC) has authorized The Columbia University Vagelos College of Physicians and Surgeons to offer up to 0.6 CEUs or 6 Category 1 contact hours for the activity Inherited Gastrointestinal Cancers and Genetic Testing. The American Board of Genetic Counseling (ABGC) will acquire CEUs earned at this session for the purposes of genetic counselor certification and recertification.

What is the significance of the Inherited Gastrointestinal Cancers and Genetic Testing CME Course?

Course Description:
This conference will present an interdisciplinary educational forum to distribute new knowledge on the identification and management of individuals and families with a genetic susceptibility to the growth of gastrointestinal cancers. This conference will outline the clinical presentation, genetic basis, and cancer risks associated with inherited cancer syndromes and combine familial cancer risk assessment, genetic testing approaches, assessment of actionable of test results, and genetic risk counseling. Didactic and case-based presentations from Columbia University and other experts in the evaluation and management of inherited gastrointestinal cancers syndromes will be featured. The goal is to enhance detection of GI cancer syndromes, understand related cancer risks, and optimize strategies for the prevention and early detection of cancers to minimize morbidity and mortality. This course will aid healthcare providers in implementing the best and most current evidence into their routine care for patients and families with inherited GI cancer syndromes.

What are the objectives of the Inherited Gastrointestinal Cancers and Genetic Testing CME Course?

Course Objectives:
At the conclusion of this CME webcast, participants will be better able to:
• Recognize and diagnose hereditary gastrointestinal syndromes
• Explain the associated cancer risks and surveillance strategies for inherited gastrointestinal cancer syndromes, along with the Lynch, polyposis, gastric cancer and familial pancreatic adenocarcinoma
• Explain the surgical approaches for the management of inherited gastrointestinal cancer syndromes for treatment and risk reduction
• Present novel approaches to screening and consequences of cancer surveillance programs in high-risk individuals
• Review the integration of genetic screening and testing results in clinical care
• Consider the utility of next-generation sequencing technologies through multigenepanel testing and tumor testing
• Define the influence of multigene panel testing to diagnose and manage inherited GIcancer syndromes
• Understand the impact of germline genomics on therapeutic options in oncology practice.